nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—kidney cancer	0.203	1	CbGaD
Fluphenazine—ABCB1—Temsirolimus—kidney cancer	0.0494	0.107	CbGbCtD
Fluphenazine—HTR2C—Sorafenib—kidney cancer	0.0473	0.103	CbGbCtD
Fluphenazine—CYP2D6—Temsirolimus—kidney cancer	0.0465	0.101	CbGbCtD
Fluphenazine—CYP1A2—Pazopanib—kidney cancer	0.0297	0.0645	CbGbCtD
Fluphenazine—ABCB1—Pazopanib—kidney cancer	0.0259	0.0564	CbGbCtD
Fluphenazine—CYP2D6—Pazopanib—kidney cancer	0.0244	0.0532	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—kidney cancer	0.0237	0.0516	CbGbCtD
Fluphenazine—CYP1A2—Erlotinib—kidney cancer	0.0212	0.0461	CbGbCtD
Fluphenazine—ABCB1—Gemcitabine—kidney cancer	0.0188	0.0408	CbGbCtD
Fluphenazine—ABCB1—Erlotinib—kidney cancer	0.0185	0.0403	CbGbCtD
Fluphenazine—CYP2D6—Erlotinib—kidney cancer	0.0174	0.0379	CbGbCtD
Fluphenazine—CYP1A2—Sorafenib—kidney cancer	0.0172	0.0374	CbGbCtD
Fluphenazine—ABCB1—Paclitaxel—kidney cancer	0.0169	0.0369	CbGbCtD
Fluphenazine—ABCB1—Sorafenib—kidney cancer	0.0151	0.0327	CbGbCtD
Fluphenazine—ABCB1—Vinblastine—kidney cancer	0.0149	0.0323	CbGbCtD
Fluphenazine—ABCB1—Vincristine—kidney cancer	0.0146	0.0318	CbGbCtD
Fluphenazine—CYP2D6—Sorafenib—kidney cancer	0.0142	0.0309	CbGbCtD
Fluphenazine—CYP2D6—Vinblastine—kidney cancer	0.014	0.0305	CbGbCtD
Fluphenazine—ABCB1—Sunitinib—kidney cancer	0.0122	0.0265	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—kidney cancer	0.00913	0.0199	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—kidney cancer	0.00861	0.0187	CbGbCtD
Fluphenazine—CYP1A2—urine—kidney cancer	0.00256	0.0848	CbGeAlD
Fluphenazine—CYP2E1—urine—kidney cancer	0.0023	0.0763	CbGeAlD
Fluphenazine—HTR2A—urine—kidney cancer	0.002	0.0663	CbGeAlD
Fluphenazine—CYP2D6—urine—kidney cancer	0.00182	0.0604	CbGeAlD
Fluphenazine—CALM3—nephron tubule—kidney cancer	0.00113	0.0375	CbGeAlD
Fluphenazine—CALM3—cortex of kidney—kidney cancer	0.000967	0.0321	CbGeAlD
Fluphenazine—CALM3—cardiac atrium—kidney cancer	0.00092	0.0305	CbGeAlD
Fluphenazine—CALM2—nephron tubule—kidney cancer	0.000888	0.0294	CbGeAlD
Fluphenazine—CALM1—nephron tubule—kidney cancer	0.000883	0.0293	CbGeAlD
Fluphenazine—HTR1A—renal system—kidney cancer	0.000821	0.0272	CbGeAlD
Fluphenazine—CALM2—renal system—kidney cancer	0.000807	0.0268	CbGeAlD
Fluphenazine—CALM1—renal system—kidney cancer	0.000803	0.0266	CbGeAlD
Fluphenazine—CALM2—kidney—kidney cancer	0.00078	0.0259	CbGeAlD
Fluphenazine—CALM1—kidney—kidney cancer	0.000776	0.0257	CbGeAlD
Fluphenazine—CALM2—cortex of kidney—kidney cancer	0.00076	0.0252	CbGeAlD
Fluphenazine—CALM1—cortex of kidney—kidney cancer	0.000756	0.0251	CbGeAlD
Fluphenazine—CALM2—gonad—kidney cancer	0.000724	0.024	CbGeAlD
Fluphenazine—CALM2—cardiac atrium—kidney cancer	0.000723	0.024	CbGeAlD
Fluphenazine—CALM1—gonad—kidney cancer	0.00072	0.0239	CbGeAlD
Fluphenazine—CALM1—cardiac atrium—kidney cancer	0.000719	0.0238	CbGeAlD
Fluphenazine—CYP1A2—renal system—kidney cancer	0.000626	0.0207	CbGeAlD
Fluphenazine—CYP2E1—nephron tubule—kidney cancer	0.000619	0.0205	CbGeAlD
Fluphenazine—Oedema peripheral—Everolimus—kidney cancer	0.000593	0.00384	CcSEcCtD
Fluphenazine—Pneumonia—Sorafenib—kidney cancer	0.000585	0.00379	CcSEcCtD
Fluphenazine—Cardiac arrest—Vincristine—kidney cancer	0.000585	0.00379	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Sunitinib—kidney cancer	0.000584	0.00378	CcSEcCtD
Fluphenazine—Anaphylactic shock—Temsirolimus—kidney cancer	0.000575	0.00372	CcSEcCtD
Fluphenazine—Hypertension—Pazopanib—kidney cancer	0.000573	0.00371	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—kidney cancer	0.000565	0.00366	CcSEcCtD
Fluphenazine—Pneumonia—Sunitinib—kidney cancer	0.000563	0.00365	CcSEcCtD
Fluphenazine—CYP2E1—renal system—kidney cancer	0.000563	0.0187	CbGeAlD
Fluphenazine—Skin disorder—Temsirolimus—kidney cancer	0.000558	0.00362	CcSEcCtD
Fluphenazine—Polyuria—Paclitaxel—kidney cancer	0.000556	0.0036	CcSEcCtD
Fluphenazine—Dry mouth—Pazopanib—kidney cancer	0.000553	0.00358	CcSEcCtD
Fluphenazine—CYP2E1—kidney—kidney cancer	0.000544	0.018	CbGeAlD
Fluphenazine—ADRA2A—cortex of kidney—kidney cancer	0.000542	0.018	CbGeAlD
Fluphenazine—Nasal congestion—Paclitaxel—kidney cancer	0.000536	0.00347	CcSEcCtD
Fluphenazine—Pneumonia—Dactinomycin—kidney cancer	0.000533	0.00345	CcSEcCtD
Fluphenazine—CYP2E1—cortex of kidney—kidney cancer	0.00053	0.0176	CbGeAlD
Fluphenazine—Renal failure acute—Paclitaxel—kidney cancer	0.000529	0.00343	CcSEcCtD
Fluphenazine—Skin disorder—Pazopanib—kidney cancer	0.000526	0.00341	CcSEcCtD
Fluphenazine—Erythema—Everolimus—kidney cancer	0.000524	0.00339	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—kidney cancer	0.000522	0.00338	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.000517	0.00335	CcSEcCtD
Fluphenazine—ADRA2A—gonad—kidney cancer	0.000516	0.0171	CbGeAlD
Fluphenazine—ADRA2A—cardiac atrium—kidney cancer	0.000515	0.0171	CbGeAlD
Fluphenazine—Dyspnoea—Temsirolimus—kidney cancer	0.000513	0.00332	CcSEcCtD
Fluphenazine—Somnolence—Temsirolimus—kidney cancer	0.000511	0.00331	CcSEcCtD
Fluphenazine—Erythema—Erlotinib—kidney cancer	0.000506	0.00327	CcSEcCtD
Fluphenazine—Pancytopenia—Vincristine—kidney cancer	0.000505	0.00327	CcSEcCtD
Fluphenazine—Muscle spasms—Everolimus—kidney cancer	0.000504	0.00326	CcSEcCtD
Fluphenazine—Decreased appetite—Temsirolimus—kidney cancer	0.0005	0.00324	CcSEcCtD
Fluphenazine—Urine output increased—Capecitabine—kidney cancer	0.000499	0.00323	CcSEcCtD
Fluphenazine—Lethargy—Paclitaxel—kidney cancer	0.000498	0.00323	CcSEcCtD
Fluphenazine—Oedema peripheral—Sunitinib—kidney cancer	0.000495	0.00321	CcSEcCtD
Fluphenazine—Agranulocytosis—Dactinomycin—kidney cancer	0.000495	0.0032	CcSEcCtD
Fluphenazine—Vision blurred—Everolimus—kidney cancer	0.000494	0.0032	CcSEcCtD
Fluphenazine—Constipation—Temsirolimus—kidney cancer	0.000492	0.00318	CcSEcCtD
Fluphenazine—HTR2A—renal system—kidney cancer	0.000489	0.0162	CbGeAlD
Fluphenazine—Photosensitivity reaction—Vincristine—kidney cancer	0.000485	0.00314	CcSEcCtD
Fluphenazine—Dyspnoea—Pazopanib—kidney cancer	0.000483	0.00313	CcSEcCtD
Fluphenazine—Agitation—Everolimus—kidney cancer	0.000482	0.00312	CcSEcCtD
Fluphenazine—Somnolence—Pazopanib—kidney cancer	0.000482	0.00312	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—kidney cancer	0.000481	0.00311	CcSEcCtD
Fluphenazine—Angioedema—Everolimus—kidney cancer	0.000479	0.0031	CcSEcCtD
Fluphenazine—Pancytopenia—Gemcitabine—kidney cancer	0.000479	0.0031	CcSEcCtD
Fluphenazine—Pneumonia—Vincristine—kidney cancer	0.000476	0.00309	CcSEcCtD
Fluphenazine—HTR2A—kidney—kidney cancer	0.000473	0.0157	CbGeAlD
Fluphenazine—Leukopenia—Vinblastine—kidney cancer	0.000471	0.00305	CcSEcCtD
Fluphenazine—Decreased appetite—Pazopanib—kidney cancer	0.000471	0.00305	CcSEcCtD
Fluphenazine—Leukopenia—Everolimus—kidney cancer	0.000469	0.00304	CcSEcCtD
Fluphenazine—Cardiac arrest—Paclitaxel—kidney cancer	0.000464	0.00301	CcSEcCtD
Fluphenazine—Polyuria—Capecitabine—kidney cancer	0.000456	0.00296	CcSEcCtD
Fluphenazine—Photosensitivity—Capecitabine—kidney cancer	0.000456	0.00296	CcSEcCtD
Fluphenazine—Erythema—Sorafenib—kidney cancer	0.000455	0.00295	CcSEcCtD
Fluphenazine—Body temperature increased—Temsirolimus—kidney cancer	0.000455	0.00294	CcSEcCtD
Fluphenazine—Hypertension—Vinblastine—kidney cancer	0.000454	0.00294	CcSEcCtD
Fluphenazine—Hypertension—Everolimus—kidney cancer	0.000452	0.00293	CcSEcCtD
Fluphenazine—Pneumonia—Gemcitabine—kidney cancer	0.000452	0.00293	CcSEcCtD
Fluphenazine—CYP2D6—renal system—kidney cancer	0.000446	0.0148	CbGeAlD
Fluphenazine—HTR2A—gonad—kidney cancer	0.000439	0.0145	CbGeAlD
Fluphenazine—Erythema—Sunitinib—kidney cancer	0.000438	0.00283	CcSEcCtD
Fluphenazine—Muscle spasms—Sorafenib—kidney cancer	0.000437	0.00283	CcSEcCtD
Fluphenazine—Dry mouth—Everolimus—kidney cancer	0.000436	0.00283	CcSEcCtD
Fluphenazine—Renal failure acute—Capecitabine—kidney cancer	0.000434	0.00281	CcSEcCtD
Fluphenazine—CYP2D6—kidney—kidney cancer	0.000431	0.0143	CbGeAlD
Fluphenazine—Blood disorder—Doxorubicin—kidney cancer	0.000426	0.00276	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000425	0.00275	CcSEcCtD
Fluphenazine—Hypersensitivity—Temsirolimus—kidney cancer	0.000424	0.00274	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—kidney cancer	0.000423	0.00274	CcSEcCtD
Fluphenazine—Dysphagia—Paclitaxel—kidney cancer	0.000422	0.00273	CcSEcCtD
Fluphenazine—Muscle spasms—Sunitinib—kidney cancer	0.000421	0.00273	CcSEcCtD
Fluphenazine—Agranulocytosis—Gemcitabine—kidney cancer	0.000419	0.00272	CcSEcCtD
Fluphenazine—Tachycardia—Everolimus—kidney cancer	0.000417	0.0027	CcSEcCtD
Fluphenazine—Angioedema—Sorafenib—kidney cancer	0.000416	0.00269	CcSEcCtD
Fluphenazine—Skin disorder—Everolimus—kidney cancer	0.000415	0.00269	CcSEcCtD
Fluphenazine—Erythema—Dactinomycin—kidney cancer	0.000414	0.00268	CcSEcCtD
Fluphenazine—Lethargy—Capecitabine—kidney cancer	0.000409	0.00265	CcSEcCtD
Fluphenazine—Leukopenia—Sorafenib—kidney cancer	0.000407	0.00264	CcSEcCtD
Fluphenazine—Pruritus—Temsirolimus—kidney cancer	0.000407	0.00263	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—kidney cancer	0.000405	0.00262	CcSEcCtD
Fluphenazine—Skin disorder—Erlotinib—kidney cancer	0.000401	0.0026	CcSEcCtD
Fluphenazine—Pancytopenia—Paclitaxel—kidney cancer	0.000401	0.0026	CcSEcCtD
Fluphenazine—Angioedema—Sunitinib—kidney cancer	0.0004	0.00259	CcSEcCtD
Fluphenazine—Hypotension—Everolimus—kidney cancer	0.0004	0.00259	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.000398	0.00257	CcSEcCtD
Fluphenazine—Oedema peripheral—Gemcitabine—kidney cancer	0.000397	0.00257	CcSEcCtD
Fluphenazine—Hypertension—Sorafenib—kidney cancer	0.000393	0.00254	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000392	0.00254	CcSEcCtD
Fluphenazine—Leukopenia—Sunitinib—kidney cancer	0.000392	0.00254	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000385	0.00249	CcSEcCtD
Fluphenazine—Pruritus—Pazopanib—kidney cancer	0.000383	0.00248	CcSEcCtD
Fluphenazine—Dyspnoea—Everolimus—kidney cancer	0.000381	0.00247	CcSEcCtD
Fluphenazine—Cardiac arrest—Capecitabine—kidney cancer	0.000381	0.00247	CcSEcCtD
Fluphenazine—Somnolence—Everolimus—kidney cancer	0.00038	0.00246	CcSEcCtD
Fluphenazine—Dry mouth—Sorafenib—kidney cancer	0.000379	0.00245	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—kidney cancer	0.000379	0.00245	CcSEcCtD
Fluphenazine—Pneumonia—Paclitaxel—kidney cancer	0.000378	0.00245	CcSEcCtD
Fluphenazine—Hypertension—Sunitinib—kidney cancer	0.000378	0.00245	CcSEcCtD
Fluphenazine—Decreased appetite—Vinblastine—kidney cancer	0.000373	0.00242	CcSEcCtD
Fluphenazine—Decreased appetite—Everolimus—kidney cancer	0.000372	0.00241	CcSEcCtD
Fluphenazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000371	0.0024	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—kidney cancer	0.000371	0.0024	CcSEcCtD
Fluphenazine—Dyspnoea—Erlotinib—kidney cancer	0.000368	0.00238	CcSEcCtD
Fluphenazine—Constipation—Vinblastine—kidney cancer	0.000367	0.00238	CcSEcCtD
Fluphenazine—Constipation—Everolimus—kidney cancer	0.000366	0.00237	CcSEcCtD
Fluphenazine—Dry mouth—Sunitinib—kidney cancer	0.000364	0.00236	CcSEcCtD
Fluphenazine—Skin disorder—Sorafenib—kidney cancer	0.000361	0.00234	CcSEcCtD
Fluphenazine—Headache—Temsirolimus—kidney cancer	0.00036	0.00233	CcSEcCtD
Fluphenazine—Decreased appetite—Erlotinib—kidney cancer	0.000359	0.00232	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—kidney cancer	0.000356	0.0023	CcSEcCtD
Fluphenazine—Constipation—Erlotinib—kidney cancer	0.000353	0.00229	CcSEcCtD
Fluphenazine—ABCB1—nephron tubule—kidney cancer	0.000353	0.0117	CbGeAlD
Fluphenazine—Abnormal dreams—Doxorubicin—kidney cancer	0.000352	0.00228	CcSEcCtD
Fluphenazine—Erythema—Gemcitabine—kidney cancer	0.000351	0.00227	CcSEcCtD
Fluphenazine—Skin disorder—Sunitinib—kidney cancer	0.000347	0.00225	CcSEcCtD
Fluphenazine—Asthma—Capecitabine—kidney cancer	0.000346	0.00224	CcSEcCtD
Fluphenazine—Dysphagia—Capecitabine—kidney cancer	0.000346	0.00224	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000346	0.00224	CcSEcCtD
Fluphenazine—Nausea—Temsirolimus—kidney cancer	0.000342	0.00221	CcSEcCtD
Fluphenazine—Agitation—Vincristine—kidney cancer	0.00034	0.0022	CcSEcCtD
Fluphenazine—Headache—Pazopanib—kidney cancer	0.000339	0.0022	CcSEcCtD
Fluphenazine—Body temperature increased—Everolimus—kidney cancer	0.000338	0.00219	CcSEcCtD
Fluphenazine—Oedema peripheral—Paclitaxel—kidney cancer	0.000333	0.00215	CcSEcCtD
Fluphenazine—Leukopenia—Vincristine—kidney cancer	0.000331	0.00215	CcSEcCtD
Fluphenazine—Dyspnoea—Sorafenib—kidney cancer	0.000331	0.00214	CcSEcCtD
Fluphenazine—Pancytopenia—Capecitabine—kidney cancer	0.000329	0.00213	CcSEcCtD
Fluphenazine—Body temperature increased—Erlotinib—kidney cancer	0.000326	0.00211	CcSEcCtD
Fluphenazine—Decreased appetite—Sorafenib—kidney cancer	0.000323	0.00209	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000322	0.00208	CcSEcCtD
Fluphenazine—Nausea—Pazopanib—kidney cancer	0.000322	0.00208	CcSEcCtD
Fluphenazine—ABCB1—renal system—kidney cancer	0.000321	0.0106	CbGeAlD
Fluphenazine—Hypertension—Vincristine—kidney cancer	0.00032	0.00207	CcSEcCtD
Fluphenazine—Dyspnoea—Sunitinib—kidney cancer	0.000318	0.00206	CcSEcCtD
Fluphenazine—Constipation—Sorafenib—kidney cancer	0.000317	0.00206	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinblastine—kidney cancer	0.000316	0.00205	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000316	0.00205	CcSEcCtD
Fluphenazine—Hypersensitivity—Everolimus—kidney cancer	0.000315	0.00204	CcSEcCtD
Fluphenazine—Leukopenia—Gemcitabine—kidney cancer	0.000314	0.00204	CcSEcCtD
Fluphenazine—Pneumonia—Capecitabine—kidney cancer	0.000311	0.00201	CcSEcCtD
Fluphenazine—Decreased appetite—Sunitinib—kidney cancer	0.000311	0.00201	CcSEcCtD
Fluphenazine—ABCB1—kidney—kidney cancer	0.00031	0.0103	CbGeAlD
Fluphenazine—Constipation—Sunitinib—kidney cancer	0.000305	0.00198	CcSEcCtD
Fluphenazine—Hypertension—Gemcitabine—kidney cancer	0.000303	0.00196	CcSEcCtD
Fluphenazine—Pruritus—Everolimus—kidney cancer	0.000303	0.00196	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—kidney cancer	0.000302	0.00196	CcSEcCtD
Fluphenazine—ABCB1—cortex of kidney—kidney cancer	0.000302	0.01	CbGeAlD
Fluphenazine—Urticaria—Sorafenib—kidney cancer	0.000295	0.00191	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—kidney cancer	0.000294	0.0019	CcSEcCtD
Fluphenazine—Erythema—Paclitaxel—kidney cancer	0.000294	0.0019	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—kidney cancer	0.000294	0.0019	CcSEcCtD
Fluphenazine—Body temperature increased—Sorafenib—kidney cancer	0.000293	0.0019	CcSEcCtD
Fluphenazine—Pruritus—Erlotinib—kidney cancer	0.000292	0.00189	CcSEcCtD
Fluphenazine—Agranulocytosis—Capecitabine—kidney cancer	0.000288	0.00187	CcSEcCtD
Fluphenazine—ABCB1—gonad—kidney cancer	0.000287	0.00953	CbGeAlD
Fluphenazine—Eczema—Doxorubicin—kidney cancer	0.000287	0.00186	CcSEcCtD
Fluphenazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000287	0.00186	CcSEcCtD
Fluphenazine—Muscle spasms—Paclitaxel—kidney cancer	0.000283	0.00183	CcSEcCtD
Fluphenazine—Body temperature increased—Sunitinib—kidney cancer	0.000282	0.00183	CcSEcCtD
Fluphenazine—Hypotension—Vincristine—kidney cancer	0.000282	0.00183	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—kidney cancer	0.00028	0.00181	CcSEcCtD
Fluphenazine—Skin disorder—Gemcitabine—kidney cancer	0.000278	0.0018	CcSEcCtD
Fluphenazine—Vision blurred—Paclitaxel—kidney cancer	0.000277	0.00179	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000274	0.00177	CcSEcCtD
Fluphenazine—Hypersensitivity—Sorafenib—kidney cancer	0.000274	0.00177	CcSEcCtD
Fluphenazine—Oedema peripheral—Capecitabine—kidney cancer	0.000273	0.00177	CcSEcCtD
Fluphenazine—Agitation—Paclitaxel—kidney cancer	0.00027	0.00175	CcSEcCtD
Fluphenazine—Headache—Vinblastine—kidney cancer	0.000269	0.00174	CcSEcCtD
Fluphenazine—Angioedema—Paclitaxel—kidney cancer	0.000269	0.00174	CcSEcCtD
Fluphenazine—Headache—Everolimus—kidney cancer	0.000268	0.00174	CcSEcCtD
Fluphenazine—Hypotension—Gemcitabine—kidney cancer	0.000268	0.00173	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—kidney cancer	0.000267	0.00173	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000267	0.00173	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—kidney cancer	0.000264	0.00171	CcSEcCtD
Fluphenazine—Leukopenia—Paclitaxel—kidney cancer	0.000263	0.0017	CcSEcCtD
Fluphenazine—Hypersensitivity—Sunitinib—kidney cancer	0.000263	0.0017	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—kidney cancer	0.000263	0.0017	CcSEcCtD
Fluphenazine—Pruritus—Sorafenib—kidney cancer	0.000263	0.0017	CcSEcCtD
Fluphenazine—Triflupromazine—BCHE—kidney cancer	0.00026	0.248	CrCbGaD
Fluphenazine—Headache—Erlotinib—kidney cancer	0.000259	0.00167	CcSEcCtD
Fluphenazine—Constipation—Vincristine—kidney cancer	0.000258	0.00167	CcSEcCtD
Fluphenazine—Dyspnoea—Gemcitabine—kidney cancer	0.000256	0.00165	CcSEcCtD
Fluphenazine—Nausea—Vinblastine—kidney cancer	0.000255	0.00165	CcSEcCtD
Fluphenazine—Somnolence—Gemcitabine—kidney cancer	0.000255	0.00165	CcSEcCtD
Fluphenazine—Nausea—Everolimus—kidney cancer	0.000254	0.00165	CcSEcCtD
Fluphenazine—Hypertension—Paclitaxel—kidney cancer	0.000254	0.00164	CcSEcCtD
Fluphenazine—Pruritus—Sunitinib—kidney cancer	0.000253	0.00164	CcSEcCtD
Fluphenazine—Decreased appetite—Gemcitabine—kidney cancer	0.000249	0.00161	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—kidney cancer	0.000249	0.00161	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—kidney cancer	0.000246	0.00159	CcSEcCtD
Fluphenazine—Constipation—Gemcitabine—kidney cancer	0.000245	0.00159	CcSEcCtD
Fluphenazine—Nausea—Erlotinib—kidney cancer	0.000245	0.00159	CcSEcCtD
Fluphenazine—Dry mouth—Paclitaxel—kidney cancer	0.000245	0.00159	CcSEcCtD
Fluphenazine—Erythema—Capecitabine—kidney cancer	0.000241	0.00156	CcSEcCtD
Fluphenazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00024	0.00155	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—kidney cancer	0.000239	0.00155	CcSEcCtD
Fluphenazine—Tachycardia—Paclitaxel—kidney cancer	0.000234	0.00152	CcSEcCtD
Fluphenazine—Skin disorder—Paclitaxel—kidney cancer	0.000233	0.00151	CcSEcCtD
Fluphenazine—Headache—Sorafenib—kidney cancer	0.000233	0.00151	CcSEcCtD
Fluphenazine—Muscle spasms—Capecitabine—kidney cancer	0.000232	0.0015	CcSEcCtD
Fluphenazine—Vision blurred—Capecitabine—kidney cancer	0.000227	0.00147	CcSEcCtD
Fluphenazine—Body temperature increased—Gemcitabine—kidney cancer	0.000227	0.00147	CcSEcCtD
Fluphenazine—Hypotension—Paclitaxel—kidney cancer	0.000224	0.00145	CcSEcCtD
Fluphenazine—Headache—Sunitinib—kidney cancer	0.000224	0.00145	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—kidney cancer	0.000223	0.00145	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—kidney cancer	0.000223	0.00145	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—kidney cancer	0.000223	0.00144	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—kidney cancer	0.000221	0.00143	CcSEcCtD
Fluphenazine—Nausea—Sorafenib—kidney cancer	0.000221	0.00143	CcSEcCtD
Fluphenazine—Leukopenia—Capecitabine—kidney cancer	0.000216	0.0014	CcSEcCtD
Fluphenazine—Dyspnoea—Paclitaxel—kidney cancer	0.000214	0.00139	CcSEcCtD
Fluphenazine—Somnolence—Paclitaxel—kidney cancer	0.000213	0.00138	CcSEcCtD
Fluphenazine—Nausea—Sunitinib—kidney cancer	0.000212	0.00137	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—kidney cancer	0.000212	0.00137	CcSEcCtD
Fluphenazine—Decreased appetite—Paclitaxel—kidney cancer	0.000209	0.00135	CcSEcCtD
Fluphenazine—Hypertension—Capecitabine—kidney cancer	0.000208	0.00135	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000207	0.00134	CcSEcCtD
Fluphenazine—Constipation—Paclitaxel—kidney cancer	0.000205	0.00133	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000204	0.00132	CcSEcCtD
Fluphenazine—Pruritus—Gemcitabine—kidney cancer	0.000203	0.00131	CcSEcCtD
Fluphenazine—Dry mouth—Capecitabine—kidney cancer	0.000201	0.0013	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—kidney cancer	0.000201	0.0013	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—kidney cancer	0.0002	0.0013	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—kidney cancer	0.000199	0.00129	CcSEcCtD
Fluphenazine—Tachycardia—Capecitabine—kidney cancer	0.000192	0.00124	CcSEcCtD
Fluphenazine—Skin disorder—Capecitabine—kidney cancer	0.000191	0.00124	CcSEcCtD
Fluphenazine—Urticaria—Paclitaxel—kidney cancer	0.000191	0.00123	CcSEcCtD
Fluphenazine—Body temperature increased—Paclitaxel—kidney cancer	0.00019	0.00123	CcSEcCtD
Fluphenazine—Headache—Vincristine—kidney cancer	0.000189	0.00123	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—kidney cancer	0.000187	0.178	CrCbGaD
Fluphenazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000186	0.0012	CcSEcCtD
Fluphenazine—Hypotension—Capecitabine—kidney cancer	0.000184	0.00119	CcSEcCtD
Fluphenazine—Headache—Gemcitabine—kidney cancer	0.00018	0.00116	CcSEcCtD
Fluphenazine—Nausea—Vincristine—kidney cancer	0.000179	0.00116	CcSEcCtD
Fluphenazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000177	0.00115	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—kidney cancer	0.000176	0.00114	CcSEcCtD
Fluphenazine—Dyspnoea—Capecitabine—kidney cancer	0.000176	0.00114	CcSEcCtD
Fluphenazine—Decreased appetite—Capecitabine—kidney cancer	0.000171	0.00111	CcSEcCtD
Fluphenazine—Nausea—Gemcitabine—kidney cancer	0.00017	0.0011	CcSEcCtD
Fluphenazine—Pruritus—Paclitaxel—kidney cancer	0.00017	0.0011	CcSEcCtD
Fluphenazine—Constipation—Capecitabine—kidney cancer	0.000168	0.00109	CcSEcCtD
Fluphenazine—Urticaria—Capecitabine—kidney cancer	0.000156	0.00101	CcSEcCtD
Fluphenazine—Body temperature increased—Capecitabine—kidney cancer	0.000156	0.00101	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—kidney cancer	0.000156	0.00101	CcSEcCtD
Fluphenazine—Headache—Paclitaxel—kidney cancer	0.00015	0.000974	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—kidney cancer	0.00015	0.000968	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—kidney cancer	0.000147	0.000949	CcSEcCtD
Fluphenazine—Hypersensitivity—Capecitabine—kidney cancer	0.000145	0.00094	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—kidney cancer	0.000143	0.000926	CcSEcCtD
Fluphenazine—Nausea—Paclitaxel—kidney cancer	0.000143	0.000923	CcSEcCtD
Fluphenazine—Pruritus—Capecitabine—kidney cancer	0.000139	0.000902	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—kidney cancer	0.000139	0.000902	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—kidney cancer	0.000134	0.00087	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—kidney cancer	0.00013	0.000839	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000127	0.000822	CcSEcCtD
Fluphenazine—Chlorpromazine—BCHE—kidney cancer	0.000126	0.12	CrCbGaD
Fluphenazine—Tachycardia—Doxorubicin—kidney cancer	0.000124	0.000802	CcSEcCtD
Fluphenazine—Headache—Capecitabine—kidney cancer	0.000123	0.000799	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—kidney cancer	0.000123	0.000799	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—kidney cancer	0.000119	0.000768	CcSEcCtD
Fluphenazine—Nausea—Capecitabine—kidney cancer	0.000117	0.000758	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—kidney cancer	0.000113	0.000733	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—kidney cancer	0.000113	0.000731	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—kidney cancer	0.00011	0.000715	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—kidney cancer	0.000109	0.000703	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—kidney cancer	0.000105	0.0997	CrCbGaD
Fluphenazine—Triflupromazine—ABCB1—kidney cancer	0.000102	0.0972	CrCbGaD
Fluphenazine—Urticaria—Doxorubicin—kidney cancer	0.000101	0.000653	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—kidney cancer	0.0001	0.00065	CcSEcCtD
Fluphenazine—Trazodone—ABCB1—kidney cancer	9.68e-05	0.0923	CrCbGaD
Fluphenazine—Hypersensitivity—Doxorubicin—kidney cancer	9.35e-05	0.000606	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—kidney cancer	8.98e-05	0.000582	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—kidney cancer	7.95e-05	0.000515	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—kidney cancer	7.54e-05	0.000488	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—kidney cancer	6.27e-05	0.0597	CrCbGaD
Fluphenazine—Quetiapine—ABCB1—kidney cancer	6.08e-05	0.0579	CrCbGaD
Fluphenazine—Chlorpromazine—ABCB1—kidney cancer	4.92e-05	0.0469	CrCbGaD
Fluphenazine—HTR1A—Signaling Pathways—IL2—kidney cancer	5.47e-06	3.6e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL2—kidney cancer	5.44e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTM1—kidney cancer	5.43e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CTNNB1—kidney cancer	5.41e-06	3.56e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—kidney cancer	5.4e-06	3.56e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	5.4e-06	3.56e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KIT—kidney cancer	5.39e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—APC—kidney cancer	5.39e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KIT—kidney cancer	5.39e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—APC—kidney cancer	5.39e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—RAF1—kidney cancer	5.36e-06	3.53e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KRAS—kidney cancer	5.34e-06	3.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—MAPK3—kidney cancer	5.34e-06	3.52e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—kidney cancer	5.33e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—RELA—kidney cancer	5.33e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCND1—kidney cancer	5.33e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—JUN—kidney cancer	5.32e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	5.32e-06	3.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	5.31e-06	3.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—POMC—kidney cancer	5.31e-06	3.5e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCND1—kidney cancer	5.3e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ERBB2—kidney cancer	5.3e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	5.3e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—JUN—kidney cancer	5.29e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	5.28e-06	3.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTEN—kidney cancer	5.27e-06	3.47e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—RAF1—kidney cancer	5.27e-06	3.47e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—RAF1—kidney cancer	5.26e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	5.26e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	5.25e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—RELA—kidney cancer	5.25e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—BRAF—kidney cancer	5.24e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—RELA—kidney cancer	5.23e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CTNNB1—kidney cancer	5.23e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CTNNB1—kidney cancer	5.23e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MTOR—kidney cancer	5.23e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	5.21e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ERBB2—kidney cancer	5.2e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—MAPK3—kidney cancer	5.16e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—MAPK3—kidney cancer	5.16e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CYP1A1—kidney cancer	5.15e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PTEN—kidney cancer	5.15e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MTOR—kidney cancer	5.14e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MTOR—kidney cancer	5.13e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—POMC—kidney cancer	5.13e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—POMC—kidney cancer	5.13e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PTEN—kidney cancer	5.12e-06	3.37e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MAPK3—kidney cancer	5.11e-06	3.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTEN—kidney cancer	5.1e-06	3.36e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTEN—kidney cancer	5.1e-06	3.36e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—kidney cancer	5.09e-06	3.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—MAPK1—kidney cancer	5.08e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—BRAF—kidney cancer	5.07e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—BRAF—kidney cancer	5.07e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—kidney cancer	5.06e-06	3.33e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MAPK3—kidney cancer	5.04e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MYC—kidney cancer	4.97e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—MAPK1—kidney cancer	4.91e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—MAPK1—kidney cancer	4.91e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MYC—kidney cancer	4.91e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.91e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	4.9e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—kidney cancer	4.9e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—kidney cancer	4.9e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MAPK3—kidney cancer	4.88e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MAPK1—kidney cancer	4.86e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTEN—kidney cancer	4.84e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.83e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.83e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.82e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—POMC—kidney cancer	4.81e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL2—kidney cancer	4.8e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MAPK1—kidney cancer	4.8e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—kidney cancer	4.8e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	4.79e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—RELA—kidney cancer	4.77e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—kidney cancer	4.74e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	4.74e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.72e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MAPK3—kidney cancer	4.72e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MAPK3—kidney cancer	4.72e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL2—kidney cancer	4.71e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCND1—kidney cancer	4.68e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	4.68e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—JUN—kidney cancer	4.67e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	4.65e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MAPK1—kidney cancer	4.64e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—kidney cancer	4.64e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—kidney cancer	4.64e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	4.64e-06	3.05e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	4.62e-06	3.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—kidney cancer	4.61e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—JUN—kidney cancer	4.6e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—kidney cancer	4.6e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—kidney cancer	4.59e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—JUN—kidney cancer	4.59e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	4.56e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	4.55e-06	3e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—kidney cancer	4.53e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—POMC—kidney cancer	4.53e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTEN—kidney cancer	4.52e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK3—kidney cancer	4.5e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MAPK1—kidney cancer	4.49e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MAPK1—kidney cancer	4.49e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTEN—kidney cancer	4.45e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTEN—kidney cancer	4.44e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTEN—kidney cancer	4.44e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTEN—kidney cancer	4.41e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	4.41e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	4.4e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	4.39e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—kidney cancer	4.38e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—kidney cancer	4.38e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	4.37e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—RAF1—kidney cancer	4.37e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK3—kidney cancer	4.36e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK3—kidney cancer	4.36e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—RELA—kidney cancer	4.35e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB2—kidney cancer	4.33e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—kidney cancer	4.3e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK1—kidney cancer	4.28e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—kidney cancer	4.28e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MTOR—kidney cancer	4.27e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—kidney cancer	4.27e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—kidney cancer	4.27e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	4.26e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	4.26e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—kidney cancer	4.25e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—kidney cancer	4.24e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—kidney cancer	4.24e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—kidney cancer	4.24e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—kidney cancer	4.24e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RAF1—kidney cancer	4.23e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RAF1—kidney cancer	4.23e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.23e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	4.22e-06	2.78e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RELA—kidney cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RELA—kidney cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	4.19e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—kidney cancer	4.19e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—kidney cancer	4.19e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	4.18e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—kidney cancer	4.18e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	4.17e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	4.16e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	4.15e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK1—kidney cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK1—kidney cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—kidney cancer	4.13e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—kidney cancer	4.13e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—kidney cancer	4.08e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—kidney cancer	4.08e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—kidney cancer	4.05e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	4.04e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—kidney cancer	4.03e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—kidney cancer	4.03e-06	2.65e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—kidney cancer	4.01e-06	2.64e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—kidney cancer	4.01e-06	2.64e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.95e-06	2.6e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.93e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—kidney cancer	3.92e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—kidney cancer	3.91e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—kidney cancer	3.91e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—kidney cancer	3.9e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—kidney cancer	3.9e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—kidney cancer	3.88e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—kidney cancer	3.88e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.86e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—POMC—kidney cancer	3.84e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—kidney cancer	3.84e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—kidney cancer	3.82e-06	2.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—kidney cancer	3.82e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.8e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—kidney cancer	3.79e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—kidney cancer	3.79e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.79e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—kidney cancer	3.79e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—kidney cancer	3.75e-06	2.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—kidney cancer	3.72e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—kidney cancer	3.7e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—kidney cancer	3.7e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—kidney cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—kidney cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—kidney cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—kidney cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.67e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—kidney cancer	3.66e-06	2.41e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—kidney cancer	3.66e-06	2.41e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.65e-06	2.41e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	3.63e-06	2.39e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.61e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.61e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	3.61e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.61e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—kidney cancer	3.6e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—kidney cancer	3.6e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—kidney cancer	3.57e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—kidney cancer	3.57e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—kidney cancer	3.51e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—kidney cancer	3.49e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—kidney cancer	3.47e-06	2.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	3.46e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—kidney cancer	3.41e-06	2.25e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—kidney cancer	3.41e-06	2.25e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—kidney cancer	3.41e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—kidney cancer	3.36e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—kidney cancer	3.34e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—kidney cancer	3.33e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	3.29e-06	2.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—kidney cancer	3.22e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—kidney cancer	3.22e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	3.19e-06	2.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—kidney cancer	3.15e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—kidney cancer	3.15e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	3.14e-06	2.07e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—kidney cancer	3.13e-06	2.06e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	3.13e-06	2.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—kidney cancer	3.11e-06	2.05e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	3.11e-06	2.05e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—kidney cancer	3.08e-06	2.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—kidney cancer	3.07e-06	2.02e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—kidney cancer	3.06e-06	2.02e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—kidney cancer	3.05e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—kidney cancer	3.05e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—kidney cancer	3.03e-06	2e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—kidney cancer	3.03e-06	1.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—kidney cancer	3.01e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—kidney cancer	3.01e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK1—kidney cancer	3e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—kidney cancer	2.97e-06	1.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—kidney cancer	2.97e-06	1.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK1—kidney cancer	2.9e-06	1.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK1—kidney cancer	2.9e-06	1.91e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.85e-06	1.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—kidney cancer	2.83e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.76e-06	1.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—kidney cancer	2.74e-06	1.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—kidney cancer	2.74e-06	1.81e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—kidney cancer	2.67e-06	1.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—kidney cancer	2.6e-06	1.72e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—kidney cancer	2.52e-06	1.66e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—kidney cancer	2.52e-06	1.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—kidney cancer	2.52e-06	1.66e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—kidney cancer	2.44e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—kidney cancer	2.44e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—kidney cancer	2.36e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.22e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.88e-06	1.24e-05	CbGpPWpGaD
